A. Boladeras

High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial

A. Zapatero, A. Guerrero, Xavier Maldonado et al. · The Lancet Oncology · 2015 · 299 citations

Urology, Radiation Medicine, Radiation Therapy +7

Quality-of-Life Impact of Primary Treatments for Localized Prostate Cancer in Patients Without Hormonal Treatment

Yolanda Pardo, Ferrán Guedea, Ferrán Aguiló et al. · Journal of Clinical Oncology · 2010 · 201 citations · Full text

Quality of life impact of treatments for localized prostate cancer: Cohort study with a 5year follow-up

Montse Ferrer, Ferrán Guedea, José Francisco Suárez et al. · Radiotherapy and Oncology · 2013 · 87 citations

Quality Of Life, Urology, Medicine +12

Short Androgen Suppression and Radiation Dose Escalation in Prostate Cancer: 12-Year Results of EORTC Trial 22991 in Patients With Localized Intermediate-Risk Disease

M. Bolla, Anouk Neven, P. Maingon et al. · Journal of Clinical Oncology · 2021 · 46 citations · Full text

High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial

A. Zapatero, A. Guerrero, Xavier Maldonado et al. · The Lancet Oncology · 2022 · 41 citations

Radiation Medicine, Urology, Medicine +7